Anticoccidial

Composition: Each 1 ml contain: Toltrazuril 25 mg

Properties: Toltrazuril induces changes in the fine structure of coccidial development stages that are mainly due to the swelling of the endoplasmic reticulum and of the Golgi apparatus and to abnormalities in the perinuclear space and disturbances in nuclear division. Toltrazuril also causes a reduction of enzymes in the respiratory chain of the parasites. Pharmacodynamic studies in laboratory animals indicated that toltrazuril had no anticoagulant, fibrinolytic, analgesic, diuretic or anticonvulsant effect. It had no effect on gastrointestinal transit time. Oral doses of up to 30 mg/kg bw had no haemodynamic or cardiac effects in anaesthetised dogs although 100mg/kg bw caused a slight tensor effect as reflected by an increase in peripheral resistance Indications: For the treatment and control of coccidiosis, Toltrazuril is effective against all intestinal stages of susceptible coccidia. To assist in the development of natural immunity to coccidiosis in breeder and layer replacer stock exposed to continuous challenge of virulent strains of coccidian Target species: Broilers and Broiler Breeders Dosage & administration: orally in drinking water. Active ingredient 7 mg / kg body weight Whole product 280ml /100kg body weight in drinking water for 25 successive days (2.5-3 ml/L) Warnings & precautions: This product is compatible with antibiotics such as enrofloxacin, ampicillin, tetracycline, tiamulin and tylosin. Contra – indication: Not to be used with chickens produces eggs for human consumption. Side – effects: No side effects in the recommended dose. Withdrawal time: 21 day Storage: Stored at temp. not exceed 30 °C Manufactured by Eva pharm distribution by "Aleffat trading "